Natürlicher D-Campher

Deutsche Apotheker Zeitung

Volumn 140, Issue 10, 2000, Pages 48-54

  Franz, Gerhard ^a   Hempel, B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAMPHOR;

ARTICLE; DRUG ISOLATION; DRUG RESEARCH; DRUG STRUCTURE; HUMAN; ORTHOSTATIC HYPOTENSION; TOXICOLOGY;

EID: 0034624817     PISSN: 00119857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Madaus G.: Lehrbuch der Biologischen Heilmittel, Monographie "Camphora". Nachdruck: G. Olms Verlag, Hildesheim, New York (1979) S. 791-800.
2. Commitee on Drugs. Camphor Revisited: Focus on Toxicity. Pediatrics 94, 127-128 (1994).
3. Hegnauer R.: Chemotaxonomie der Pflanzen. Birkhäuser Verlag, Basel und Stuttgart (1996) S. 354-358.
4. Tschirch, A.: Handbuch der Pharmakognosie. H. Tauchnitz-Verlag, Leipzig (1917) S. 1108-1138.
5. Monographie Camphora, Campher. Bundesanzeiger No. 228 vom 05.12. 1984 (korr. Bundesanzeiger No. 50 vom 13.03. 1990).
6. Masaki K.H., Schatz I.J., Burchfiel C.M., Sharp D.S., Chiu D., Foley D., Curb J.D.: Orthostatic Hypotension Predicts Mortality in Elderly Men. The Honolulu Heart Program. Circulation 18, 2290-2295 (1998).
7. Masuo K., Mikami N., Ogihara T.: The Frequency of Orthostatic Hypotension in Elderly Patients with Essential Hypertension, Isolated Systolic Hypertension and Borderline Hypertension. J. Hypertens. 11, Suppl. 5, 5306-5307 (1993).
8. Herrmann V., Butzer R., Roll S., Malerczyk C, Belz G.G.: Hemodynamic Responses to a Cumulative Dosage of Korodin® Herz-Kreislauf-Tropfen (Poster). Eur. J. Clin. Pharmacol. 50, 544 (1996).
9. Schmidt U., Albrecht M., Podzuweit H.: Clinically Relevant Improvement in Work Tolerance of Patients with Heart-Failure Receiving a High Dose Crataegus-Campher Combination (Poster). Eur. J. Clin. Pharmacol. 50, 553 (1996).
10. Monographie Kampfer-Bäder. Bundesanzeiger vom 30.10. 1991.
11. Hager's Handbuch der Pharmazeutischen Praxis, Bd. 7, Bruchhausen R., Ebel S., Frahm A.W., Hackenthal E. (Hrsg.). Springer-Verlag, Berlin, Heidelberg, New York (1993), p. 645-650.
12. Gibşon D.E., Moore G.P., Pfaff J.A.: Camphor ingestion. Am. J. Emergency Med. 7, 41-43 (1989).
13. Hempel B.: Erkenntnismaterial zu "Cinnamomum camphora". Kooperation Phytopharmaka, Bonn 1999.
14. Jimenez J.F., Brown, A.L., Arnold, W.C., Byrne, W.J.: Chronic camphor ingestion mimicking Reye's syndrome. Gastroenterology 84, 394-398 (1983).
15. Leuschner J.: Examination of D-Camphor on Convulsions in Mice Following Oral Administration (safety pharmacology study). LPT-Report Nr. 10142/96 vom 11.04. 1997 an die Firma Robugen GmbH, D-73730 Esslingen.
16. Leuschner, J.: Reproduktive Toxicity Studies of D-Camphor in Rats and Rabbits. Arzneimittelforschung 47, 124-128 (1997).
17. Navarro H. A., Price C. J., Marr M. C., Myers C. B., Heindel J. J.: Developmental Toxicity Evaluation of 'd'-Camphor (CAS No. 464-49-3) Administered by Gavage to Sprague-Dawley CD (trade name) Rats on Gestational Days 6 through 15. Final Study Report and Appendix, National Toxicology Program, Research Triangle Park, NC (1992) PB92-170034.
18. Navarro H. A., Price C. J., Marr M. C., Myers C. B., Heindel J. J.: Final Report on the Developmental Toxicity of 'd'-Camphor (CAS No. 464-49-3) in New Zealand White (NZW) (trade name) Rabbits. National Toxicology Program, Research Triangle Park, NC (1992) PB93 - 123784.